Cite

HARVARD Citation

    Tanaka, H. et al. (n.d.). P-060 Mid- to Long-Term Outcomes of Adalimumab Maintenance Treatment for Japanese Patients with Crohn's Disease and Associated Prognostic Factors. Inflammatory bowel diseases. p. . [Online]. 
  
Back to record